Dare Bioscience
DARE
27 hedge funds and large institutions have $2.46M invested in Dare Bioscience in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 12 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
0.02% more ownership
Funds ownership: 0.58% → 0.59% (+0.02%)
25% less funds holding
Funds holding: 36 → 27 (-9)
27% less capital invested
Capital invested by funds: $3.35M → $2.46M (-$888K)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AE
AMH Equity
Great Neck,
New York
|
+$373K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$39.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$28.1K |
| 4 |
State Street
Boston,
Massachusetts
|
+$13.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$79.1K |
| 2 |
BlackRock
New York
|
-$77.7K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$62K |
| 4 |
FFS
Founders Financial Securities
Towson,
Maryland
|
-$60.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$37.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $84 | +$5 | +1 | +5% |
|
|
CSC
27
Caldwell Sutter Capital
Sausalito,
California
| $67 | – | – | – |
|
|
CPG
28
Cornerstone Planning Group
Fairfield,
New Jersey
| $7 | -$5 | -1 | Closed |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$79.1K | -13,440 | Closed |
|
|
30
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$62K | -10,492 | Closed |
|
|
FFS
31
Founders Financial Securities
Towson,
Maryland
| – | -$60.8K | -10,333 | Closed |
|
|
XT
32
XTX Topco
George Town,
Cayman Islands
| – | -$13.8K | -2,341 | Closed |
|
|
OS
33
Objectivity Squared
Charleston,
South Carolina
| – | -$12.9K | -2,250 | Closed |
|
|
FAFN
34
First Affirmative Financial Network
Colorado Springs,
Colorado
| – | -$5.99K | -1,018 | Closed |
|
35
HighTower Advisors
Chicago,
Illinois
| – | -$5K | -900 | Closed |
|
|
FPF
36
First Pacific Financial
Vancouver,
Washington
| – | -$4.9K | -833 | Closed |
|
37
Wells Fargo
San Francisco,
California
| – | -$378 | -64 | Closed |
|
|
NA
38
NewEdge Advisors
New Orleans,
Louisiana
| – | -$5 | -1 | Closed |
|
DARE Hedge Fund Activity: Q2 2024 in Review
27 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2024, worth a combined $2.46M — down 27% from $3.35M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of DARE and 3 opened new positions — a net loss of 9 holders — while 6 trimmed existing stakes and 10 added.
The largest buyer was AMH Equity, opening a new position worth an estimated $373K. The largest seller was Citadel Advisors, exiting entirely with an estimated $79.1K sold.
- 27 institutional investors held Dare Bioscience (DARE) as of Q2 2024, down from 36 in Q1 2024.
- Funds reported $2.46M of Dare Bioscience stock for Q2 2024, down 27% quarter-over-quarter.
- 3 funds opened new Dare Bioscience positions in Q2 2024 and 12 closed out, a net change of -9 holders.
- The largest Dare Bioscience buyer in Q2 2024 was AMH Equity, an estimated $373K added.
- The largest Dare Bioscience seller in Q2 2024 was Citadel Advisors, an estimated $79.1K sold.
Based on aggregated 13F filings for Q2 2024.